Oracle CORP Form 4 insider transactions

NYSE
Director William G. Parrett reports acquisition and disposal of Oracle common stock and restricted stock units on May 31, 2024.
NYSE
Director Leon E. Panetta reports acquisition and disposal of Oracle Corp stock and restricted stock units on May 31, 2024.
NYSE
Director Charles Moorman IV reports acquisition and disposal of Oracle common stock and restricted stock units.
NYSE
Director Renee James reported the acquisition and disposal of Oracle common stock and restricted stock units on May 31, 2024.
NYSE
Director Rona Alison Fairhead reports acquisition and disposal of Oracle common stock and restricted stock units.
NYSE
Director George H. Conrades reported the acquisition and disposal of Oracle common stock and restricted stock units on May 31, 2024.
NYSE
Director Bruce R. Chizen reports acquisition and disposal of Oracle common stock and restricted stock units on May 31, 2024.
NYSE
Director Michael J. Boskin reports acquisition and disposal of Oracle common stock and restricted stock units.
NYSE
Director Jeffrey Berg reports acquisition and disposal of Oracle stock and restricted stock units.
NYSE
Director Awo Ablo reports acquisition and disposal of Oracle common stock and restricted stock units on May 31, 2024.
NYSE
Director Michael J. Boskin exercised stock options and sold 45,000 shares of Oracle common stock on May 7, 2024, according to a recent SEC filing.
NYSE
Director George H. Conrades exercised stock options and sold 20,000 shares of Oracle common stock on May 3, 2024.
NYSE
Director George H. Conrades exercised stock options and sold 25,000 shares of Oracle (ORCL) common stock on May 1, 2024.
NYSE
Oracle's Chief Corporate Architect, Edward Screven, reports acquiring restricted stock units as a result of accrued dividend equivalents on previously granted units.
NYSE
EVP and Chief Legal Officer of Oracle, Stuart Levey, reports the acquisition of dividend equivalents related to previously granted restricted stock units.
NYSE
Oracle CEO Safra Catz reports exercising stock options and selling shares of common stock between March 25 and March 27, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Director Jeffrey Berg exercised stock options and sold Oracle shares on March 18, 2024, according to a Form 4 filing with the SEC.
NYSE
Oracle's Vice Chairman Jeffrey Henley exercised a stock option and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.